{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:08:58Z","timestamp":1788952138349,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ehjcvp\/pvag068","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:42:08Z","timestamp":1787827328000},"source":"Crossref","is-referenced-by-count":0,"title":["What comes after CLOSURE-AF? Rethinking antithrombotic therapy after left atrial appendage closure"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-4512","authenticated-orcid":false,"given":"Shuichiro","family":"Yamauchi","sequence":"first","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University , 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-2888","authenticated-orcid":false,"given":"Hiroyuki","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University , 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-0010","authenticated-orcid":false,"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University , 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026090904520418300_pvag068-B1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med"},{"key":"2026090904520418300_pvag068-B2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2026090904520418300_pvag068-B3","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026090904520418300_pvag068-B4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090904520418300_pvag068-B5","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left atrial appendage closure or anticoagulation for atrial fibrillation","volume":"394","author":"Doshi","year":"2026","journal-title":"N Engl J Med"},{"key":"2026090904520418300_pvag068-B6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2024.05.067","article-title":"Anticoagulation alone vs anticoagulation plus aspirin or dual antiplatelet therapy following left atrial appendage occlusion","volume":"84","author":"Reinhardt","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026090904520418300_pvag068-B7","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090904520418300_pvag068-B8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026090904520418300_pvag068-B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ehjcvp\/pvaf078","article-title":"Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis","volume":"12","author":"Samaras","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026090904520418300_pvag068-B10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090904520418300_pvag068-B11","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090904520418300_pvag068-B12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"2026090904520418300_pvag068-B13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1253\/circj.CJ-25-0678","article-title":"Management strategies for patients with atrial fibrillation-related ischemic stroke despite oral anticoagulation","volume":"90","author":"Chatani","year":"2025","journal-title":"Circ J"},{"key":"2026090904520418300_pvag068-B14","author":"ClinicalTrials.gov"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag068\/70818134\/pvag068.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvag068\/70818134\/pvag068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:12:22Z","timestamp":1788948742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article\/doi\/10.1093\/ehjcvp\/pvag068\/8771705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvag068","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"pvag068"}}